AdvaMed Encourages HHS CER Inventory Efforts; Drug Groups Press For Delay
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed is encouraging Health and Human Services' efforts to start building a centralized inventory of comparative effectiveness research, even as drug industry groups complain the project would be "premature" before a congressionally established public-private institute gets up and running